Loading...
Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
The treatment or prevention of bleeding in patients with hemophilia A relies on replacement therapy with different factor VIII (FVIII)-containing products or on the use of by-passing agents, i.e., activated prothrombin complex concentrates or recombinant activated factor VII. Emerging approaches inc...
Na minha lista:
| Udgivet i: | Haematologica |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Ferrata Storti Foundation
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7109737/ https://ncbi.nlm.nih.gov/pubmed/31289204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.210583 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|